Disruption of the cytoskeleton in Alzheimer's disease

https://doi.org/10.1016/0959-4388(95)80073-5Get rights and content

Abstract

Paired helical filaments (PHFs) in Alzheimer's disease are formed from hyperphosphorylated brain tau known as PHF—tau. Many sites of phosphorylation that were thought to be present only in PHF—tau are now known to be normal phosphate acceptor sites in both fetal and rapidly processed adult brain tau. The rapid dephosphorylation of normal brain tau by protein phosphatases 2A and 2B provides an explanation for the apparent absence of phosphates at these sites in the normal adult brain tau obtained postmortem. Although the functional significance of each of these normal phosphate acceptor sites is unknown at this time, emerging evidence suggests that the binding of tau to microtubules is regulated by the simultaneous phosphorylation and dephosphorylation of tau at multiple sites.

References (43)

  • G Linwall et al.

    Phosphorylation affects the ability of tau to promote microtubule assembly

    J Biol Chem

    (1984)
  • S Lovestone et al.

    Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells

    Curr Biol

    (1994)
  • R-W Shin et al.

    Alzheimer disease A68 proteins injected into rat brain induce codeposits of β-amyloid, ubiquitin, and α-1 antichymotrypsin

    Proc Natl Acad Sci USA

    (1993)
  • DJ Selkoe

    Normal and abnormal biology of the β-amyloid precursor protein

    Annu Rev Neurosci

    (1994)
  • JQ Trojanowski et al.

    Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias

    Ann NY Acad Sci

    (1994)
  • E-M Mandelkow et al.

    Tau as a marker of Alzheimer's disease

    Trends Biochem Sci

    (1993)
  • PA Arriagada et al.

    Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

    Neurology

    (1992)
  • DW Dickson et al.

    Identification of normal and pathological aging in prospectively studied nondemented elderly humans

    Neurobiol Aging

    (1991)
  • C Hock et al.

    Increased levels of τ in cerebrospinal fluid of patients with Alzheimer's disease — correlation with degree of cognitive impairment

    Ann Neurol

    (1995)
  • H Mori et al.

    Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau

    Neurosci Lett

    (1995)
  • C Bancher et al.

    Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects

    Acta Neuropathol

    (1994)
  • Cited by (78)

    • Protein phosphatase 2A as therapeutic targets in various disease models

      2018, Life Sciences
      Citation Excerpt :

      The proposed mechanism of increased miR-1 activity contributes to initiation of arrhythmia in chronic atrial fibrillation due to altered Ca2+ handling and impaired atrial contractility [82]. Tau is a microtubule associated protein which once phosphorylated by kinases is reported to play an important role in regulating axonal microtubule dynamics to support neuronal and synaptic functions [6,49,68,81]. PP2A present in brain dephosphorylate tau and thus play a preventive role.

    • Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese

      2011, Brain Research
      Citation Excerpt :

      The MAPT H1 haplotype and subhaplotypes may be associated with sporadic tauopathies including AD (Baker et al., 1999; Myers et al., 2005; Pittman et al., 2005; Myers et al., 2007; Kwok et al., 2004; Laws et al., 2007). And that, tau's phosphorylation is regulated by many protein kinases (Lee, 1995), including glycogen synthase kinase 3beta (GSK3B) (Rankin et al., 2007). Glycogen synthase kinase 3 (GSK3) has two homologous isoforms, GSK3A and GSK3B.

    View all citing articles on Scopus
    View full text